See Polaris Partners’ activity on LinkedIn

3,373 followers

4mo

We're excited to share that we've received Fast Track Designation in AML! https://lnkd.in/e-JYPBdP

$News: Auron Therapeutics Announces AUTX-703 Granted Fast Track Designation by the FDA for Relapsed or Refractory Acute Myelogenous Leukemia$

4 Comments

Chief Corporate and Business Development Officer

4mo

Congrats!

Founder and CEO of Clin Ops Solutions LLC

4mo

Congrats :)))

Providing growth phase Biotech & Pharma companies access to leading talent across Clinical, Patient Safety & Medical Affairs

4mo

Head of Computational Biology at Auron

4mo

So awesome!

See more comments

To view or add a comment, sign in

Polaris Partners’ Post